Instil Bio Inc.
TIL | NASDAQ
$6.57
-$0.23 (-3.38%)
Nov 2, 2026, 3:53 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.03 | -1.68 | -0.32 | -0.37 | -11.56 | -89.78 |
PEG Ratio | 0.17 | 0.03 | 0.01 | -0.02 | -0.03 | -0.19 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 24.56K |
PB Ratio | 0.64 | 0.73 | 0.22 | 0.22 | 3.27 | 11.59 |
P/FCF Ratio | -2 | -1.89 | -0.48 | -0.31 | -10.08 | -42.15 |
P/OCF Ratio | -2 | -2.23 | -0.60 | -0.45 | -14.85 | -114.46 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -21.46K |
Debt / Equity Ratio | 0.75 | 0.51 | 0.38 | 0.22 | n/a | n/a |
Quick Ratio | 39.53 | 15.76 | 15.22 | 8.22 | 11.22 | 18.53 |
Current Ratio | 39.53 | 15.76 | 15.22 | 8.22 | 11.22 | 18.53 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0 |
Interest Coverage | -9.08 | -8.18 | -30.56 | -109.49 | n/a | n/a |
Return on Equity | -62.68% | -43.75% | -69.12% | -61.38% | -28.24% | -12.91% |
Return on Assets | -35.07% | -28.13% | -47.93% | -46.29% | -25.70% | -11.83% |
Return on Invested Capital | -26.58% | -28.58% | -50.24% | -45.22% | -27.36% | -11% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 100% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -27.35K% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -27.24K% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -24.38K% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -58.28K% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -24.19K% |
Add to Watchlist
Select watchlists to add or remove TIL